Invention Title:

VASCULARIZED CENTRAL NERVOUS SYSTEM (CNS) ORGANOIDS AND METHODS OF PREPARING THE SAME

Publication number:

US20260317705

Publication date:
Section:

Chemistry; metallurgy

Class:

C12N5/0619

Inventors:

Applicant:

Smart overview of the Invention

The method involves creating a central nervous system (CNS) organoid by culturing stem cells under specific neuronal differentiation conditions for a set period. A separate mesoderm organoid is cultured using different stem cells under mesodermal differentiation conditions for another time frame. The CNS organoid cells are then dissociated and co-cultured with the intact mesoderm organoid. This co-culturing process is essential for developing a vascularized CNS organoid that mimics the physiological conditions of actual CNS tissues.

Components of Organoids

The developed organoid includes neurons or neural progenitor cells, microglia cells, and a microvascular network. These components are crucial for the organoid's functionality, allowing it to be immunocompetent and capable of mimicking real CNS tissues. The microglia cells within the organoid can express specific markers and respond to inflammatory stimuli, showcasing their functional similarity to in vivo conditions.

Significance of Microvascular Networks

Integrating microvascular networks into CNS organoids addresses a significant limitation of traditional organoids, which often lack such features. The presence of these networks enhances physiological fidelity, enabling better studies of neurovascular and neuroimmune interactions. The method's success hinges on the specific co-culture conditions and the use of biomaterial scaffolds, which support the development of these intricate networks.

Immunocompetence and Inflammatory Response

The organoids are designed to be immunocompetent, with microglia cells capable of mounting an inflammatory response when exposed to stressors like oligomeric Tau. This feature is crucial for studying neurological diseases and the immune responses within the CNS. The organoids express inflammatory markers such as CCL2, CXCL8, and CXCL10, indicating their potential to model disease states effectively.

Potential Applications

These advanced CNS organoids offer significant potential for research into human neurodevelopment and neurological disorders. By providing a more accurate representation of CNS tissues, they can be used to study disease mechanisms, test drug responses, and explore neurovascular and neuroimmune interactions. The method described allows for the creation of organoids that closely mimic in vivo conditions, making them a valuable tool in medical research.